Skip to content

Transcranial direct current stimulation in patient with chronic post-stroke with cognitive rehabiliation treatment at home

The exploratory study for the improvement of cognition of Transcranial direct current stimulation in chronic post-stroke patient with cognitive rehabiliation treatment at home.

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CRIS
Registry ID
KCT0003427
Enrollment
30
Registered
2019-01-15
Start date
2018-08-24
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : The objective of this study is to investigate the effect of the tDCS therapy during home cognitive traning treatment at 4 weeks after onset in chronic post-stroke patients with cognit

Sponsors

Ybrain
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) 20~85 YO adult/ Female and Male (2) Stroke patient including Ischemic stroke, Hemorrhagic stroke (3) Chronic stroke patient (6 months after stroke onset) (4) K-MoCA Test < 26 (5) Understanding the Informed consent form and patients who have decided to voluntarily participate and have agreed to the written consent of the subject and are able to respond to the questionnaire

Exclusion criteria

Exclusion criteria: (1) A person who is diagnosed with other Axis I disorder like a Major Schizophrenia or Bipolar Diesease or Degenerative dementia. (2) A person who is determined to be excluded for using tDCS medical device for other reason - medical device is inserted in the body (e.g. pace maker) - metal plate is inserted on head - Attachment area If there is a wound on the skin - epilepsy - pregnance - do not agree with pregnant women and contraception etc. - If you suspect problems with DC stimulation electrodes due to deformity of the scalp, inflammation or other dermatological problems (3) The K-MoCA scale <= 9 (4) A person who is not suitable for this clinical trial based on principal investigator’s determination other than above reasons

Design outcomes

Primary

MeasureTime frame
The average scale of K-DRS-II

Secondary

MeasureTime frame
The average scale of K-DRS-II;*Assessing administrative capabilities: Go-no Go, Fluency, Stroop, TMT A/B, *Assessing working memory: N-back, *Assessing language learning ability: Verbal Learning Test, *Simple cognitive function evaluation: K-MoCA, *language ability evaluation: K-BNT,*depression evaluation: K-GDS, Short form, *quality of life evaluation: EQ-5D;Safety evaluation

Countries

Korea, Republic of

Contacts

Public ContactYUNHEE KIM

Samsung Medical Center

yun1225.kim@samsung.com+82-2-3410-2814

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 11, 2026